Name
Tezacitabine
Alternate Names
FMdC
KW-2331
MDL 101731
Abbreviations
None
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
None
Primary Site
Histology
None
Remarks
Phase I/II (colorectal, other) Phase II (AML, NSCLC, ovarian) Nucleotide analog. Matrix Pharmaceuticals; Chiron.
Coding
This drug should be coded